Notice for lenvatinib (as mesilate) (Eisai Australia Pty Ltd)
Active ingredients
lenvatinib (as mesilate)
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Hard capsule
Indication
For the treatment of hepatocellular carcinoma (HCC)
Therapeutic area
Oncology